Last Updated: 06/10/2025

Characterization of the activity of the protein aggregation inhibitor YAT2150 as a new antimalarial mechanism

Objectives

Principal Institution

Institute for Bioengineering of Catalonia (IBEC), Spain

External reference

Project details

Themes

Basic Science
Drug-based Strategies
Enabling Technologies & Assays

Date

Jan 2022

Total Project Funding

$117,504

Funding Details
Ministry of Science and Innovation (MICINN), Spain

Grant ID: PRE2022-101493
EUR 111,758
Country / Project Site(s)

Spain

SHARE

Related Resources

Response plan to pfhrp2 gene deletions, second edition
Guidance & Strategy
Ifakara Masterclass Edition 33- Infected But Not Sick: A MasterClass with Profs. Chris Drakeley & Teun Bousema
Multimedia

Related Projects

Jan 2021

$214,624

Characterization of the activity of the protein aggregation inhibitor YAT2150 as a new antimalarial mechanism
Institute for Bioengineering of Catalonia (IBEC), Spain
Oct 2023 —
Sep 2025

$536,918

GBi3M: Chlorotonil derivatives, a novel class of substances with anti-malarial effects (ChloroMalaria-2) – Characterization of the anti-malarial activity of dehalogenil
Tübingen University, Germany
SHARE